A Sibling's Dementia May Mean Shorter Life Span for Brothers, Sisters
By Ernie Mundell HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- A study involving twins suggests that if you have a sibling who develops dementia, that might not bode well for your life span.
That's true even if you don't go on to develop dementia yourself, according to a study from U.S. and Swedish researchers.
One investigator was surprised by the finding.
“We expected a different result. We expected that, in twins where one developed dementia and the other did not, the difference in life span would be just like we see in unrelated people,” said lead study author Jung Yun Jang.
She led the trial as part of her doctoral studies in the department of psychology at the University of Southern California (USC), in Los Angeles. The object of the study, funded by the National Institutes of Health, was to assess typical life span after a dementia diagnosis.
"One of the most frequently asked questions when a family member receives a diagnosis of dementia is: How much time do we have?” Jang noted in a USC news release.
The study involved 90 pairs of identical twins (who share all their genes) and 288 pairs of fraternal twins, all from a 40-year database out of Sweden known as the Swedish Twin Registry.
In all sets of twins used in in the new study, one twin had developed dementia while the other had not.
As has been seen in other studies, the average life span after a dementia diagnosis was about seven years, the researchers reported Dec. 11 in Alzheimer's and Dementia.
Among this study's twins, specifically:
Life span post-diagnosis was roughly similar for the identical twins where one is diagnosed with dementia
Among the fraternal twins, when one is diagnosed with dementia, the twin unaffected by dementia has a slightly shortened life span, compared to people who have no sibling with dementia
Why would simply having a sibling with dementia lower a person's life span? The team say it's not clear, although the shared environment siblings grow up in could play a role.
For example, if both developed unhealthy dietary or other habits in childhood, that could lead to a shared risk for heart disease decades later. Doctors already know that heart disease raises dementia risk, and for the sibling unaffected by dementia, heart disease could work to shorten life span there, too.
“We assumed the reason a person who has developed dementia has a shortened life expectancy is because the dementia leads to other medical conditions that affect mortality,” Jang said. “What we’re seeing instead is the increased risk of mortality is not due to just the dementia itself, but also a whole package of other influences that the person brings to their disease.”
Much of that "package of influences" begins early in life.
“What happens early in the life course is really important,” said study co-author Margaret Gatz, a professor of psychology, gerontology and preventive medicine at USC. “You may not be able to change that for yourself, but it does seem like the message to parents is, make sure your kid eats healthy, make sure your kid gets exercise, make sure your kid gets an education. You’re actually contributing to giving that kid a lower chance of developing dementia 75 years later.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 00:15
Read more
- One in Six Emergency Departments Have High Pediatric Readiness
- Lower Risk for Asthma Seen With Younger Age at Natural Menopause
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
- Bird Flu Infects 1 in 14 Dairy Workers Exposed; CDC Urges Better Protections
- Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions